| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2005.11.040 |
| P698 | PubMed publication ID | 16364513 |
| P2093 | author name string | Edwin V Oaks | |
| K Ross Turbyfill | |||
| P2860 | cites work | Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri | Q33588750 |
| Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602 | Q33876803 | ||
| Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults | Q34008338 | ||
| Immunogenicity of a 26-valent group A streptococcal vaccine. | Q34121015 | ||
| Detection and differentiation of iron-responsive avirulent mutants on Congo red agar | Q34416025 | ||
| Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine | Q34545910 | ||
| Gastroenteritis in US Marines during Operation Iraqi Freedom | Q34555095 | ||
| Shigella flexneri infection: pathogenesis and vaccine development. | Q35671854 | ||
| Small-animal model to measure efficacy and immunogenicity of Shigella vaccine strains | Q36989057 | ||
| Isolation and characterization of a Shigella flexneri invasin complex subunit vaccine | Q39517102 | ||
| Construction, characterization, and animal testing of WRSd1, a Shigella dysenteriae 1 vaccine | Q39655324 | ||
| Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection | Q39822312 | ||
| Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine | Q40155606 | ||
| Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial | Q40501431 | ||
| Transient increase in diarrheal diseases after the devastating earthquake in Kocaeli, Turkey: results of an infectious disease surveillance study. | Q42046748 | ||
| Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones | Q43996596 | ||
| Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis | Q44965347 | ||
| Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years | Q50131898 | ||
| Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults. | Q54572055 | ||
| Towards a vaccine candidate against Shigella dysenteriae 1: expression of the Shiga toxin B-subunit in an attenuated Shigella flexneri aroD carrier strain. | Q54579896 | ||
| Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial | Q56925522 | ||
| Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei | Q67941446 | ||
| Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model | Q70573636 | ||
| Serum antibody responses against shigella lipopolysaccharides and invasion plasmid-coded antigens in shigella infected Swedish patients | Q72715742 | ||
| Construction and characterization of genetically-marked bivalent anti-Shigella dysenteriae 1 and anti-Shigella flexneri Y live vaccine candidates | Q73426744 | ||
| Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition | Q73507076 | ||
| Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III | Q73570985 | ||
| Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle | Q74335025 | ||
| Meningococcal vaccines | Q80511370 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Shigella flexneri | Q1644417 |
| P304 | page(s) | 2290-2301 | |
| P577 | publication date | 2005-12-05 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine | |
| P478 | volume | 24 |
| Q38284501 | An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children |
| Q37668395 | An update on vaccines against Shigella |
| Q52337397 | Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of Shigella Artificial Invaplex. |
| Q35805439 | Broadly protective Shigella vaccine based on type III secretion apparatus proteins |
| Q34394744 | Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity |
| Q36844719 | Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road |
| Q38586531 | Convergent synthesis of the tetrasaccharide repeating unit of the O-antigen of Shigella boydii type 9. |
| Q37643320 | Development and preclinical evaluation of a trivalent, formalin-inactivated Shigella whole-cell vaccine. |
| Q30443288 | Enteric infections, diarrhea, and their impact on function and development |
| Q37032264 | Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD. |
| Q38952300 | Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae. |
| Q40460000 | Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain. |
| Q40123700 | Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. |
| Q38648043 | In silico analysis to identify vaccine candidates common to multiple serotypes of Shigella and evaluation of their immunogenicity. |
| Q47578477 | In silico design of a novel chimeric shigella IpaB fused to C terminal of clostridium perfringens enterotoxin as a vaccine candidate. |
| Q37640115 | Inactivated and subunit vaccines to prevent shigellosis |
| Q36689023 | Live-attenuated Shigella vaccines |
| Q34601845 | Mucosal adjuvant properties of the Shigella invasin complex |
| Q37156758 | Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines |
| Q43623067 | Nanoparticle-based vaccine for mucosal protection against Shigella flexneri in mice |
| Q51058305 | Parenteral immunization with IpaB/IpaD protects mice against lethal pulmonary infection by Shigella. |
| Q38068954 | Recent progress towards development of a Shigella vaccine |
| Q38294092 | Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta) |
| Q30369367 | Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate. |
| Q84554549 | Safety and immunogenicity of a Shigella flexneri 2a Invaplex 50 intranasal vaccine in adult volunteers |
| Q84592118 | Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine |
| Q36920244 | Shigella antigen-specific B memory cells are associated with decreased disease severity in subjects challenged with wild-type Shigella flexneri 2a. |
| Q35653427 | Shigella flexneri infection in a newly acquired rhesus macaque (Macaca mulatta) |
| Q35201253 | Shigella flexneri: a three-year antimicrobial resistance monitoring of isolates in a Children Hospital, Ahvaz, Iran |
| Q43432983 | Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection. |
| Q56383780 | Shigellosis |
| Q36969851 | Type III secretion systems and disease |
| Q33578045 | Vaccines against human diarrheal pathogens: current status and perspectives |
| Q35887055 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. |
Search more.